87 related articles for article (PubMed ID: 17240182)
61. Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis.
Pons R; Ford B; Chiriboga CA; Clayton PT; Hinton V; Hyland K; Sharma R; De Vivo DC
Neurology; 2004 Apr; 62(7):1058-65. PubMed ID: 15079002
[TBL] [Abstract][Full Text] [Related]
62. [Molecular genetics of aromatic L-amino acid decarboxylase].
Ichinose H; Nagatsu T
Yakubutsu Seishin Kodo; 1993 Aug; 13(4):251-6. PubMed ID: 8237142
[TBL] [Abstract][Full Text] [Related]
63. AADC deficiency: occurring in humans, modeled in rodents.
Hwu WL; Lee NC; Chien YH; Muramatsu S; Ichinose H
Adv Pharmacol; 2013; 68():273-84. PubMed ID: 24054149
[TBL] [Abstract][Full Text] [Related]
64. A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency.
Allen GF; Land JM; Heales SJ
Mol Genet Metab; 2009 May; 97(1):6-14. PubMed ID: 19231266
[TBL] [Abstract][Full Text] [Related]
65. Aromatic Amino Acid Decarboxylase Deficiency: The Added Value of Biochemistry.
Montioli R; Borri Voltattorni C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808712
[TBL] [Abstract][Full Text] [Related]
66. Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook.
Himmelreich N; Montioli R; Bertoldi M; Carducci C; Leuzzi V; Gemperle C; Berner T; Hyland K; Thöny B; Hoffmann GF; Voltattorni CB; Blau N
Mol Genet Metab; 2019 May; 127(1):12-22. PubMed ID: 30952622
[TBL] [Abstract][Full Text] [Related]
67. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency.
Wassenberg T; Molero-Luis M; Jeltsch K; Hoffmann GF; Assmann B; Blau N; Garcia-Cazorla A; Artuch R; Pons R; Pearson TS; Leuzzi V; Mastrangelo M; Pearl PL; Lee WT; Kurian MA; Heales S; Flint L; Verbeek M; Willemsen M; Opladen T
Orphanet J Rare Dis; 2017 Jan; 12(1):12. PubMed ID: 28100251
[TBL] [Abstract][Full Text] [Related]
68. [Localization of non-monoaminergic aromatic L-amino acid decarboxylase neurons (D-neurons) in the human striatum and their functional significance].
Ikemoto K
Kaibogaku Zasshi; 2002 Dec; 77(4):71-5. PubMed ID: 12557414
[TBL] [Abstract][Full Text] [Related]
69. Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus.
Fusco C; Leuzzi V; Striano P; Battini R; Burlina A; ; Spagnoli C
Ital J Pediatr; 2021 Jan; 47(1):13. PubMed ID: 33478565
[TBL] [Abstract][Full Text] [Related]
70. [Expression of the enzymes of dopamine synthesis in non-dopaminergic neurons: functional significance and regulation].
Ugriumov MV
Usp Fiziol Nauk; 2007; 38(4):3-20. PubMed ID: 18064905
[TBL] [Abstract][Full Text] [Related]
71. [Brain neurons partly expressing monoaminergic phenotype: distribution, development, and functional significance].
Ugriumov MV
Usp Fiziol Nauk; 2007; 38(2):3-25. PubMed ID: 17578016
[TBL] [Abstract][Full Text] [Related]
72. Compound Heterozygosis in AADC Deficiency and Its Complex Phenotype in Terms of AADC Protein Population.
Bisello G; Bertoldi M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232540
[TBL] [Abstract][Full Text] [Related]
73. Aromatic L-amino acid decarboxylase deficiency in countries in the Middle East: a case series and literature review.
Abukhaled M; Al Muqbil M; Alghamdi MA; Hundallah K; Suleiman J; Ben-Omran T; Alfadhel M; Almannai M; Alsaleh R; Tabarki B
Eur J Pediatr; 2023 Jun; 182(6):2535-2545. PubMed ID: 36928758
[TBL] [Abstract][Full Text] [Related]
74. Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines.
Marín-Valencia I; Serrano M; Ormazabal A; Pérez-Dueñas B; García-Cazorla A; Campistol J; Artuch R
Clin Biochem; 2008 Nov; 41(16-17):1306-15. PubMed ID: 18790694
[TBL] [Abstract][Full Text] [Related]
75. Eladocagene Exuparvovec: First Approval.
Keam SJ
Drugs; 2022 Sep; 82(13):1427-1432. PubMed ID: 36103022
[TBL] [Abstract][Full Text] [Related]
76. A review of aromatic l-amino acid decarboxylase (AADC) deficiency in Taiwan.
Lee NC; Chien YH; Hwu WL
Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):226-229. PubMed ID: 30614627
[TBL] [Abstract][Full Text] [Related]
77. L-dopa therapy for Parkinson's disease: past, present, and future.
Nagatsua T; Sawadab M
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S3-8. PubMed ID: 19131039
[TBL] [Abstract][Full Text] [Related]
78. Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme.
Berry MD; Juorio AV; Li XM; Boulton AA
Neurochem Res; 1996 Sep; 21(9):1075-87. PubMed ID: 8897471
[TBL] [Abstract][Full Text] [Related]
79. Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review.
Rizzi S; Spagnoli C; Frattini D; Pisani F; Fusco C
Behav Neurol; 2022; 2022():2210555. PubMed ID: 36268467
[TBL] [Abstract][Full Text] [Related]
80. [Gene therapy for Parkinson's disease].
Muramatsu S
Brain Nerve; 2007 Apr; 59(4):425-30. PubMed ID: 17447529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]